Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Alcee Jumonville
A Phase II Study of AZD2171 (Cediranib) in the Treatment of Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Leukemia and Lymphoma
Cancer Research
Oncology
Hematology
Related publications
Final Results of a Phase 2, Open-Label Study of Indisulam, Idarubicin, and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome
Cancer
Cancer Research
Oncology
Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Phase I Trial of SAR103168, a Novel Multi-Kinase Inhibitor, in Patients With Refractory/Relapsed Acute Leukemia or High-Risk Myelodysplastic Syndrome
Leukemia and Lymphoma
Cancer Research
Oncology
Hematology
Sequential Allogeneic Stem Cell Transplantation in High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
CD30 Expression in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndromes
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Myelodysplastic Syndrome, Juvenile Myelomonocytic Leukemia, and Acute Myeloid Leukemia Associated With Complete or Partial Monosomy 7
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Superior Outcome With Hypomethylating Therapy in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome and Chromosome 5 and 7 Abnormalities
Cancer
Cancer Research
Oncology
Pattern Associated Leukemia Immunophenotypes and Measurable Disease Detection in Acute Myeloid Leukemia or Myelodysplastic Syndrome With Mutated NPM1
Cytometry Part B - Clinical Cytometry
Forensic Medicine
Pathology
Histology
Cell Biology
Low Dose Melphalan Is a Treatment Option in Elderly Patients With High Risk Myelodysplastic Syndrome or Secondary Acute Myeloblastic Leukaemia
Haematologia
